Press Releases

The global infectious disease treatment market is anticipated to grow at an 8.3% CAGR during the forecast period. Infectious diseases occur by several organisms that include bacteria, fungi, viruses, and parasites. Contagious infectious diseases can be spread from person to person. Few of these infectious diseases are spread by insect or animal bites, and some are acquired through the consumption of contaminated water or food. Infectious diseases include acquired immunodeficiency syndrome (AIDS), tuberculosis (TB), Hepatitis B, and others. The COVID-19 pandemic is one of the major market factors for the growth of the global infectious disease treatment market. The large number of innovative drugs that were released during the pandemic helped the market to generate enormous market income over time. In addition, the rising prominence of infectious diseases such as TB and AIDS globally, increased geriatric population, attractive reimbursement policies, the upsurge in healthcare expenditure, and rising awareness among patients about preventive measures will drive the market share for the global infectious disease treatment industry.

In June 2023, Pfizer Inc. announced that findings from late-stage trials showed that their experimental antibiotic combination was effective in treating severe illnesses caused by drug-resistant bacteria. Antibiotic-resistant bacteria, often known as superbugs, are killing people all around the world, and health officials have called for the discovery of innovative therapies as resistance to older antibiotics rises.

Bowse 63 market data Tables and 40 Figures spread through 200 Pages and in-depth TOC on "Infectious Disease Treatment Market by Mode of Treatment (Drugs and Vaccines), by Target Organism (Antibacterial, Antifungal, Antiviral, Antiparasitic, and Others), by Disease Type (Bacterial, Viral, Parasitic, and Fungal), by End User (Online Pharmacies, Research Organisations, Retail Pharmacies, and Hospitals & Clinics), and Region" - Global Forecast to 2030

By Target Organism, Antifungal Drugs are expected to have a high CAGR during the forecast period.

The Global Infectious Disease Treatment Market is classified into Antibacterial, Antifungal, Antiviral, Antiparasitic, and Others based on Target Organism. The antibacterial drugs are further divided into Quinolones, Beta Lactams, Tetracyclines, Sulfonamides, and Others. The antifungal drugs are further divided into Azoles, Echinodians, Polyenes, Pyrimidines, and Others. Antifungal Drugs category is anticipated to grow at a high CAGR during the forecast period due to the rising incidence of fungal infections globally and are used in combination with other treatments like antibiotics.

Global Infectious Disease Treatment Segmentation Analysis

Discover More About This Report, Download A Free Sample Copy of the Global Infectious Disease Treatment Market

“Asia-Pacific is expected to witness the fastest growth during the forecast period in the Global Infectious Disease Treatment Industry.”

The Asia Pacific region is expected to grow at a faster pace over the coming years due to high unmet clinical requirements combined with rapidly improving healthcare infrastructure, particularly in developing nations like India and China, which have been severely affected by various infectious diseases on a global scale, including Ebola virus disease (EVD), Marburg virus disease (MARV), and Lassa fever, etc.

Some of the major players in the global Infectious Disease Treatment industry include Merck & Co., Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd, GSK plc, AstraZeneca, Novartis AG, Mylan N.V., Sanofi, Gilead Sciences, Inc., Bayer AG.

Scope of the Report

Global Infectious Disease Treatment Market Coverage

Mode of Treatment Insight and Forecast 2018-2030

• Drugs
  • Oral Administration
  • Topical
  • Injections
  • Others
• Vaccines

Target Organism Insight and Forecast 2018-2030

• Antibacterial
  • Quinolones
  • Beta Lactams
  • Tetracyclines
  • Sulfonamides
  • Others
• Antifungal
  • Azoles
  • Echinodians
  • Polyenes
  • Pyrimidines
  • Others
• Antiviral
• Antiparasitic
• Others

Disease Type Insight and Forecast 2018-2030

• Bacterial
  • Tuberculosis
  • Bacterial Meningitis
  • Others
• Viral
  • AIDS
  • Hepatitis B
  • Hepatitis C
  • Others
• Parasitic
• Fungal

End User Insight and Forecast 2018-2030

• Online Pharmacies
• Research Organisations
• Retail Pharmacies
• Hospitals & Clinics

Geographical Segmentation

Infectious Disease Treatment Market by Region

North America

• By Mode of Treatment
• By Target Organism
• By Disease Type
• By End User
• By Country – U.S., Canada, and Mexico

Europe

• By Mode of Treatment
• By Target Organism
• By Disease Type
• By End User
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Mode of Treatment
• By Target Organism
• By Disease Type
• By End User
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Mode of Treatment
• By Target Organism
• By Disease Type
• By End User
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries